Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
Access to Samples (REMS/CREATES)
Biosimilars
Disposal of Unused Drugs
Drug Approval Process (GDUFA/BsUFA)
Drug Prices
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Board of Directors
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
Access and Savings Report
Blog
Amicus Briefs
Press Releases
Biosimilars Handbook
Generics Savings by State
Join
Take Action
Menu
Breadcrumb
Home
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilars
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Infographic
Nov 19, 2019
| Erica Klinger
USMCA: Nothing to See Here (Infographic)
Blog
Nov 19, 2019
| Jonathan Kimball
Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA
Blog
Nov 18, 2019
| Erica Klinger
Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner
Blog
Nov 14, 2019
| Erica Klinger
How Our Associate Members Make the World Healthier
Blog
Nov 11, 2019
| Erica Klinger
GRx+Biosims Year 2: The Recap
Press Release
Nov 1, 2019
| Rachel Schwartz
AAM Statement on Nomination of Dr. Stephen Hahn to FDA
Blog
Oct 29, 2019
| Rachel Schwartz
AAM Testimony on the Generic Global Supply Chain—Five Takeaways
Press Release
Oct 29, 2019
| Rachel Schwartz
AAM Statement on 2019 FDA Drug Shortages Task Force Report
Blog
Oct 29, 2019
| Jennifer Soup
GRx+Biosims: Back + Better Than Ever
Press Release
Oct 23, 2019
| Rachel Schwartz
AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.
Blog
Oct 22, 2019
| Erica Klinger
Associate Member Operation Smile: A Catalyst for Increasing Access to Safe Surgery
Press Release
Oct 16, 2019
| Rachel Schwartz
AAM Reaction to FDA Statement on Patient Access to Generic Drugs
Load More
Advocacy
Issue Overview
Access to Samples (REMS/CREATES)
Biosimilars
Disposal of Unused Drugs
Drug Approval Process (GDUFA/BsUFA)
Drug Prices
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
Access! 2020
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Board of Directors
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
Access and Savings Report
Blog
Amicus Briefs
Press Releases
Biosimilars Handbook
Generics Savings by State
Join
Take Action